Ruxolitinib . phosphate salt

Ruxolitinib . phosphate salt
COVID-19 Research
Item number Size Datasheet Manual SDS Delivery time Quantity Price
AG-CR1-3645-M005 5 mg -

3 - 9 business days*

50.00€
AG-CR1-3645-M025 25 mg -

3 - 9 business days*

110.00€
AG-CR1-3645-M100 100 mg -

3 - 9 business days*

264.00€
 
White to off-white solid. Soluble in DMSO (>100mg/ml) and water (8mg/ml). Slightly soluble in... more
Product information "Ruxolitinib . phosphate salt"
White to off-white solid. Soluble in DMSO (>100mg/ml) and water (8mg/ml). Slightly soluble in 100% ethanol. Water-soluble phosphate salt of Ruxolitinib, Antineoplastic, anti-inflammatory and immunomodulating agent, Orally bioavailable potent ATP mimetic that inhibits both JAK1 and JAK2 with IC50 values of 2.7 and 4.5nM, respectively and is less selective for JAK3 (IC50=322nM), Affects DC differentiation and function, leading to impaired T cell activation, Used in the treatment of myeloproliferative neoplasms and psoriasis, Anticancer agent. Shown to induce apoptosis and autophagy, Potent and selective inhibitor of HIV-1 replication and virus reactivation in vitro.
Keywords: INCB018424, INC 424
Supplier: AdipoGen Life Sciences
Supplier-Nr: AG-CR1-3645

Properties

Application: JAK1?/?JAK2 inhibitor
MW: 404,4 D
Formula: C17H18N6 . H3O4P
Purity: >97%
Format: Solid

Database Information

CAS : 1092939-17-7| Matching products
KEGG ID : K11217 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: +20°C)
Signal Word: Warning
GHS Hazard Pictograms:
H Phrases: H302, H315, H319, H361, H373
P Phrases: P202, P260, P270, P280, P314, P330, P301+P312, P302+P352, P305+P351+P338, P308+P313, P332+P313, P337+P313, P405
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Ruxolitinib . phosphate salt"
Write a review
or to review a product.
Viewed